227 related articles for article (PubMed ID: 37592287)
41. Mechanisms underlying mutational signatures in human cancers.
Helleday T; Eshtad S; Nik-Zainal S
Nat Rev Genet; 2014 Sep; 15(9):585-98. PubMed ID: 24981601
[TBL] [Abstract][Full Text] [Related]
42. Both cell autonomous and non-autonomous processes modulate the association between replication timing and mutation rate.
Vardi-Yaacov O; Yaacov A; Rosenberg S; Simon I
Sci Rep; 2023 Aug; 13(1):13143. PubMed ID: 37573368
[TBL] [Abstract][Full Text] [Related]
43. Two main mutational processes operate in the absence of DNA mismatch repair.
Németh E; Lovrics A; Gervai JZ; Seki M; Rospo G; Bardelli A; Szüts D
DNA Repair (Amst); 2020 May; 89():102827. PubMed ID: 32126497
[TBL] [Abstract][Full Text] [Related]
44. Mutational Strand Asymmetries in Cancer Genomes Reveal Mechanisms of DNA Damage and Repair.
Haradhvala NJ; Polak P; Stojanov P; Covington KR; Shinbrot E; Hess JM; Rheinbay E; Kim J; Maruvka YE; Braunstein LZ; Kamburov A; Hanawalt PC; Wheeler DA; Koren A; Lawrence MS; Getz G
Cell; 2016 Jan; 164(3):538-49. PubMed ID: 26806129
[TBL] [Abstract][Full Text] [Related]
45. Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes.
Perera D; Poulos RC; Shah A; Beck D; Pimanda JE; Wong JW
Nature; 2016 Apr; 532(7598):259-63. PubMed ID: 27075100
[TBL] [Abstract][Full Text] [Related]
46. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
[TBL] [Abstract][Full Text] [Related]
47. Biallelic mutations in cancer genomes reveal local mutational determinants.
Demeulemeester J; Dentro SC; Gerstung M; Van Loo P
Nat Genet; 2022 Feb; 54(2):128-133. PubMed ID: 35145300
[TBL] [Abstract][Full Text] [Related]
48. Intragenomic variability and extended sequence patterns in the mutational signature of ultraviolet light.
Lindberg M; Boström M; Elliott K; Larsson E
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20411-20417. PubMed ID: 31548379
[TBL] [Abstract][Full Text] [Related]
49. Frequent POLE-driven hypermutation in ovarian endometrioid cancer revealed by mutational signatures in RNA sequencing.
Davila JI; Chanana P; Sarangi V; Fogarty ZC; Weroha SJ; Guo R; Goode EL; Huang Y; Wang C
BMC Med Genomics; 2021 Jun; 14(1):165. PubMed ID: 34158040
[TBL] [Abstract][Full Text] [Related]
50. Mutational signatures reveal ternary relationships between homologous recombination repair, APOBEC, and mismatch repair in gynecological cancers.
Farmanbar A; Firouzi S; Kneller R; Khiabanian H
J Transl Med; 2022 Feb; 20(1):65. PubMed ID: 35109853
[TBL] [Abstract][Full Text] [Related]
51. Genome destabilizing mutator alleles drive specific mutational trajectories in Saccharomyces cerevisiae.
Stirling PC; Shen Y; Corbett R; Jones SJ; Hieter P
Genetics; 2014 Feb; 196(2):403-12. PubMed ID: 24336748
[TBL] [Abstract][Full Text] [Related]
52. Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig.
Rubanova Y; Shi R; Harrigan CF; Li R; Wintersinger J; Sahin N; Deshwar AG; ; Morris QD;
Nat Commun; 2020 Feb; 11(1):731. PubMed ID: 32024834
[TBL] [Abstract][Full Text] [Related]
53. LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations.
Lochovsky L; Zhang J; Fu Y; Khurana E; Gerstein M
Nucleic Acids Res; 2015 Sep; 43(17):8123-34. PubMed ID: 26304545
[TBL] [Abstract][Full Text] [Related]
54. Deficiency of nucleotide excision repair is associated with mutational signature observed in cancer.
Jager M; Blokzijl F; Kuijk E; Bertl J; Vougioukalaki M; Janssen R; Besselink N; Boymans S; de Ligt J; Pedersen JS; Hoeijmakers J; Pothof J; van Boxtel R; Cuppen E
Genome Res; 2019 Jul; 29(7):1067-1077. PubMed ID: 31221724
[TBL] [Abstract][Full Text] [Related]
55. The interaction between cytosine methylation and processes of DNA replication and repair shape the mutational landscape of cancer genomes.
Poulos RC; Olivier J; Wong JWH
Nucleic Acids Res; 2017 Jul; 45(13):7786-7795. PubMed ID: 28531315
[TBL] [Abstract][Full Text] [Related]
56. Identification of multiplicatively acting modulatory mutational signatures in cancer.
Kičiatovas D; Guo Q; Kailas M; Pesonen H; Corander J; Kaski S; Pitkänen E; Mustonen V
BMC Bioinformatics; 2022 Dec; 23(1):522. PubMed ID: 36474143
[TBL] [Abstract][Full Text] [Related]
57. A practical framework and online tool for mutational signature analyses show inter-tissue variation and driver dependencies.
Degasperi A; Amarante TD; Czarnecki J; Shooter S; Zou X; Glodzik D; Morganella S; Nanda AS; Badja C; Koh G; Momen SE; Georgakopoulos-Soares I; Dias JML; Young J; Memari Y; Davies H; Nik-Zainal S
Nat Cancer; 2020 Feb; 1(2):249-263. PubMed ID: 32118208
[No Abstract] [Full Text] [Related]
58. Sequence and structure signatures of cancer mutation hotspots in protein kinases.
Dixit A; Yi L; Gowthaman R; Torkamani A; Schork NJ; Verkhivker GM
PLoS One; 2009 Oct; 4(10):e7485. PubMed ID: 19834613
[TBL] [Abstract][Full Text] [Related]
59. Identification of the mutation signature of the cancer genome caused by irradiation.
Kageyama SI; Du J; Kaneko S; Hamamoto R; Yamaguchi S; Yamashita R; Okumura M; Motegi A; Hojo H; Nakamura M; Tsuchihara K; Akimoto T
Radiother Oncol; 2021 Feb; 155():10-16. PubMed ID: 33075393
[TBL] [Abstract][Full Text] [Related]
60. Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis.
Petljak M; Alexandrov LB; Brammeld JS; Price S; Wedge DC; Grossmann S; Dawson KJ; Ju YS; Iorio F; Tubio JMC; Koh CC; Georgakopoulos-Soares I; Rodríguez-Martín B; Otlu B; O'Meara S; Butler AP; Menzies A; Bhosle SG; Raine K; Jones DR; Teague JW; Beal K; Latimer C; O'Neill L; Zamora J; Anderson E; Patel N; Maddison M; Ng BL; Graham J; Garnett MJ; McDermott U; Nik-Zainal S; Campbell PJ; Stratton MR
Cell; 2019 Mar; 176(6):1282-1294.e20. PubMed ID: 30849372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
